Targeting reduction of proteinuria in glomerulonephritis: Maximizing the antifibrotic effect of valsartan by protecting podocytes. [electronic resource]
Producer: 20151117Description: 177-89 p. digitalISSN:- 1752-8976
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Animals
- Dose-Response Relationship, Drug
- Fibrosis
- Glomerulonephritis -- complications
- Intracellular Signaling Peptides and Proteins -- biosynthesis
- Kidney -- pathology
- Kidney Function Tests
- Male
- Membrane Proteins -- biosynthesis
- Podocytes -- drug effects
- Proteinuria -- drug therapy
- Rats
- Rats, Sprague-Dawley
- Tetrazoles -- therapeutic use
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.